From UT Southwestern: Hypertension: RAS blockade, hyperkalemia, and AKI

http://www.ncbi.nlm.nih.gov/pubmed/22473512

Nat Rev Nephrol. 2012 Apr 3. doi: 10.1038/nrneph.2012.62. [Epub ahead of print]

Hypertension: RAS blockade, hyperkalemia and AKI-look and you will find.

Toto RD.

Source

University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. robert.toto@utsouthwestern.edu.

Orally active renin inhibitors are a potent and relatively new class of antihypertensive agents and the effect of this class of antihypertensive agents on serum potassium levels has not been fully evaluated. A member of this drug class, aliskiren, was approved for the treatment of hypertension in March 2007.